Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • HeraMED and Telstra Health come together to launch remote maternity solution HeraCARE
    • News

    HeraMED and Telstra Health come together to launch remote maternity solution HeraCARE

    Medical data and technology company HeraMED (ASX: HMD)’s subsidiary HeraCARE is gearing up for its soft launch with Telstra. It will soon be available to medical practices using Telstra Health’s MedicalDirector patient management software. In November 2023, HeraMED initially announced its partnership with Telstra Health’s MedicalDirector platform, which serves GPs and healthcare professionals. HeraCARE is

    Read More
    Public
  • Mosaic Brands struggles continue as retailer flags lower consumer spending
    • News

    Mosaic Brands struggles continue as retailer flags lower consumer spending

    Australian fashion retailer Mosaic Brands (ASX: MOZ)—the company behind brands like Noni B, Millers, Rockmans, Katies, Crossroads and Beme—has reported a challenging second half of FY24, citing disruptions in its supply chain and a decrease in consumer spending as key factors impacting its financial performance.  Despite a strong first half with a $13.1 million EBIT,

    Read More
    Public
  • Tech leads US markets lower, though most sectors close higher – XJO to rise
    • Market Update

    Tech leads US markets lower, though most sectors close higher – XJO to rise

    The XJO is expected to open modestly higher this morning, with futures pointing to an open around the potential resistance at 7,775. That 7,775 level has been a sticking point for the past week, so if we push through that level is could indicate further upwards movement. There might be an additional level of resistance

    Read More
    Public
  • Testing methylone for PTSD treatment: Emyria’s Centre appointed site for clinical trial
    • News

    Testing methylone for PTSD treatment: Emyria’s Centre appointed site for clinical trial

    Biotechnology company Emyria (ASX: EMD), which develops treatments for mental health and neurological conditions, has newly inaugurated its treatment facility Empax Centre. The centre has been selected as a key site for a clinical trial sponsored by New York-based Transcend Therapeutics.  The trial will evaluate the safety and efficacy of methylone, a novel rapid-acting neuroplastogen

    Read More
    Public
  • TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays
    • News

    TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays

    So you’ve seen self-driving cars and drones, now gear up for an autonomous wheelchair that dispels the need for joysticks. In wheelchair users, atrophying muscles can make it challenging to use the joystick properly, thus losing control of their wheelchair. That’s where digitising the experience further helps.  Medical device company Control Bionics (ASX: CBL)’s autonomous

    Read More
    Public
  • XJO to drift lower with US markets closed for a public holiday
    • Market Update

    XJO to drift lower with US markets closed for a public holiday

    The XJO is expected to open moderately lower this morning, with futures pointing to an open around 7,750. Yesterday our market again held resistance around 7,775 – 7,800, which would have to break for further gains to look likely. To the downside, 7,700 is the key support to watch. Our market seems to be in

    Read More
    Public
  • «
  • ‹
  • 64
  • 65
  • 66
  • 67
  • 68
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.